Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

EOS imaging announces first installation in Middle East

EOS imaging, the pioneer in 2D/3D orthopedic medical imaging, announced its entry into the Middle East market with a first installation in Saudi Arabia.

Jeddah Scan Radiology Center’s commitment to dose reduction and 3D modeling resulted in the decision to exclusively offer EOS exams for axial skeleton diagnosis, planning and control.

The EOS system installed at the Jeddah Scan Radiology Center in Saudi Arabia is the first in the Middle East. The Center serves referring physicians who specialize in orthopedics, rheumatology and pediatrics at several key regional hospitals.

Now that the EOS technology is available, the Jeddah Scan Center intends to reach a broad base of prescribers who are looking for the added value that EOS exams provide for better, less irradiating treatment of patients in an urban area of 3.4 million.

The EOS platform provides 2D and 3D full-body, stereo-radiographic images of patients in functional positions. EOS exams require a radiation dose 50% to 85% less than Digital Radiology and 95% less than basic CT scans.

The new EOS Micro Dose system, recently cleared by the Food and Drug Administration, marks another important step towards the ALARA principle (As Low As Reasonably Available). This latest technology has made the dose for a pediatric spine follow-up exam equivalent to a week of natural background radiation on Earth.

Marie Meynadier, CEO of EOS imaging said, "We’re excited to enter the Middle Eastern market, especially in a city like Jeddah, Saudi Arabia, which has come to be considered a center of excellence in medical care. As part of our commitment to our shareholders and future patients, we are thrilled to see the EOS platform reach a new and important market with significant potential."

EOS imaging designs, develops, and markets EOS, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopaedics, as well as associated solutions.

The company is authorized to market in 48 countries, including the United States (FDA), Japan and the European Union (EC). The Group posted 2014 revenues of €20.1 million and employs 107 people including an R&D team of 39 engineers.

The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.